NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) — By FMW Media new on the road / Newsmax TV announces the schedule of its nationally syndicated 1-hour TV show this Sunday, September 18, 2022, airtime 10-11 a.m. ET.
New to The Street The 386th TV episode contains eight (8) interviews from the following companies and their representatives:
1). Acurx Pharmaceuticals, Inc ACXP ($ACXP) interview with David Luci, President/CEO.
2). property – Soho real estate Interview with Sharif El Gamal, CEO.
3). Phixey, Inc Interview with Alexandra Poirier, Communications Manager.
4). metaverse – CEEK VRs (CRYPTO: $CEEK) ($CEEK) Interview with Mary Spio, CEO/Founder.
5). Virios Therapeutics Inc VIRI ($VIRI) interview with Greg Duncan, CEO.
6). Sekur Private Data, Ltd SWISS SKU GDT Interview with Mr. Alain Ghiai, CEO.
7). Micro Cellular Sciences’ (A division of Lifeist Wellness, Inc.) LFST (FRANKFURT: M5B) NXTTF Interview with Faraaz Jamal, CEO, Mikra Cellular Sciences & COO, Lifeist Wellness, Inc.
8th). “The Sekur Privacy & Sekur Security” segment Interview with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data Ltd. SWISS SKU GDT (Sekur®).
This week, New to The Street TV welcomes David Luci, President/CEO Acurx Pharmaceuticals, Inc. ACXP ($ACXP). Of the Nasdaq marketplace studio, David speaks to TV presenter Jane King about the company’s clinical biopharmaceutical business, which is developing a new class of antibiotics for bacterial infections. David discusses the company’s novel Ibezapolstat druga possible treatment for clostridioids difficult infections (CDI). With the recent FDA positive clinical phase 2a result of Ibezapolstat and microbiome Data, the company is now enrolling patients for its FDA phase 2b study. CDI kills about 29,000 people annually; many catch the infection in hospitals and nursing homes. Clinical data to date shows that Ibezapolstat increases the good microbiome bacteria in the gut and it showed…
